PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 106 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 3.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $53,000 | -15.9% | 18,476 | -10.1% | 0.00% | – |
| Q4 2021 | $63,000 | -56.6% | 20,554 | -0.3% | 0.00% | – |
| Q3 2021 | $145,000 | -52.1% | 20,612 | -37.6% | 0.00% | – |
| Q2 2021 | $303,000 | +19.3% | 33,053 | +26.2% | 0.00% | – |
| Q1 2021 | $254,000 | -11.8% | 26,182 | -6.7% | 0.00% | – |
| Q4 2020 | $288,000 | -92.3% | 28,055 | -92.5% | 0.00% | -100.0% |
| Q3 2020 | $3,757,000 | -44.0% | 372,257 | -42.1% | 0.00% | -40.0% |
| Q2 2020 | $6,710,000 | +45.6% | 643,337 | +17.8% | 0.01% | +25.0% |
| Q1 2020 | $4,608,000 | -23.3% | 546,058 | -20.5% | 0.00% | 0.0% |
| Q4 2019 | $6,008,000 | -18.8% | 686,757 | -0.1% | 0.00% | -20.0% |
| Q3 2019 | $7,401,000 | -40.4% | 687,685 | -29.6% | 0.01% | -28.6% |
| Q2 2019 | $12,422,000 | -19.2% | 977,484 | +146.5% | 0.01% | -22.2% |
| Q1 2019 | $15,378,000 | +52.1% | 396,487 | -20.2% | 0.01% | +28.6% |
| Q4 2018 | $10,113,000 | -31.8% | 497,035 | +53.6% | 0.01% | +75.0% |
| Q3 2018 | $14,835,000 | -8.8% | 323,586 | +17.7% | 0.00% | -20.0% |
| Q2 2018 | $16,259,000 | -13.0% | 274,888 | +0.1% | 0.01% | -44.4% |
| Q1 2018 | $18,686,000 | -29.5% | 274,640 | +2.5% | 0.01% | -47.1% |
| Q4 2017 | $26,489,000 | -63.4% | 267,986 | -55.6% | 0.02% | -66.0% |
| Q3 2017 | $72,316,000 | +313.0% | 603,908 | +201.4% | 0.05% | +316.7% |
| Q2 2017 | $17,509,000 | +127.4% | 200,354 | -3.2% | 0.01% | +100.0% |
| Q1 2017 | $7,701,000 | -15.5% | 207,047 | -30.3% | 0.01% | -14.3% |
| Q4 2016 | $9,115,000 | +7.8% | 296,971 | +135.5% | 0.01% | +16.7% |
| Q3 2016 | $8,453,000 | +191.5% | 126,082 | +29.4% | 0.01% | +200.0% |
| Q2 2016 | $2,900,000 | +242.4% | 97,416 | +237.3% | 0.00% | +100.0% |
| Q1 2016 | $847,000 | -95.5% | 28,881 | -88.0% | 0.00% | -92.3% |
| Q4 2015 | $18,798,000 | -29.6% | 239,788 | -32.4% | 0.01% | -38.1% |
| Q3 2015 | $26,713,000 | +63.3% | 354,508 | +152.9% | 0.02% | +110.0% |
| Q2 2015 | $16,363,000 | -40.8% | 140,175 | +19.7% | 0.01% | -41.2% |
| Q1 2015 | $27,643,000 | +37.2% | 117,081 | +10.0% | 0.02% | +41.7% |
| Q4 2014 | $20,144,000 | +26.2% | 106,441 | +59.1% | 0.01% | +20.0% |
| Q3 2014 | $15,960,000 | +206.5% | 66,907 | -15.2% | 0.01% | +150.0% |
| Q2 2014 | $5,208,000 | +8.5% | 78,929 | +71.2% | 0.00% | +33.3% |
| Q1 2014 | $4,799,000 | +33.9% | 46,104 | +33.1% | 0.00% | 0.0% |
| Q4 2013 | $3,585,000 | +1.8% | 34,646 | -47.2% | 0.00% | 0.0% |
| Q3 2013 | $3,523,000 | – | 65,676 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |